Amalgamated Bank Boston Scientific Corp Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Boston Scientific Corp stock. As of the latest transaction made, Amalgamated Bank holds 296,304 shares of BSX stock, worth $26.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

296,304

Previous 296,750 0.15%

Holding current value

$26.8 Million

Previous $22.9 Million 8.65%

% of portfolio

0.2%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$72.96 - $84.0 $32,540 - $37,464	-446 Reduced 0.15%	296,304 $24.8 Million
Q2 2024 Aug 12, 2024	SELL	$67.33 - $77.71 $432,931 - $499,675	-6,430 Reduced 2.12%	296,750 $22.9 Million
Q1 2024 Apr 23, 2024	SELL	$57.6 - $68.62 $3.1 Million - $3.69 Million	-53,741 Reduced 15.06%	303,180 $20.8 Million
Q4 2023 Feb 06, 2024	SELL	$48.64 - $57.81 $898,672 - $1.07 Million	-18,476 Reduced 4.92%	356,921 $20.6 Million
Q3 2023 Nov 08, 2023	BUY	$50.19 - $54.68 $225,102 - $245,239	4,485 Added 1.21%	375,397 $19.8 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $249,942 - $274,675	-5,027 Reduced 1.34%	370,912 $20.1 Million
Q1 2023 May 02, 2023	BUY	$45.09 - $50.03 $98,792 - $109,615	2,191 Added 0.59%	375,939 $18.8 Million
Q4 2022 Feb 10, 2023	BUY	$39.56 - $47.22 $160,811 - $191,949	4,065 Added 1.1%	373,748 $17.3 Million
Q3 2022 Nov 09, 2022	BUY	$36.71 - $109.66 $190,818 - $570,012	5,198 Added 1.43%	369,683 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $238,187 - $318,348	6,759 Added 1.89%	364,485 $13.6 Million
Q1 2022 Jun 30, 2022	SELL	$40.9 - $45.1 $1.04 Million - $1.15 Million	-25,479 Reduced 6.65%	357,726 $15.8 Million
Q4 2021 Feb 15, 2022	SELL	$38.07 - $44.87 $72,713 - $85,701	-1,910 Reduced 0.5%	383,205 $16.3 Million
Q3 2021 Oct 29, 2021	SELL	$41.23 - $45.88 $535,165 - $595,522	-12,980 Reduced 3.26%	385,115 $16.7 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $12.3 Million - $14.2 Million	320,078 Added 410.27%	398,095 $17 Million
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $106,127 - $119,367	-3,009 Reduced 3.71%	78,017 $3.02 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $5,734 - $7,260	-173 Reduced 0.21%	81,026 $2.91 Million
Q3 2020 Oct 30, 2020	SELL	$34.44 - $42.23 $8,024 - $9,839	-233 Reduced 0.29%	81,199 $3.1 Million
Q2 2020 Aug 10, 2020	SELL	$30.19 - $39.11 $4.55 Million - $5.89 Million	-150,586 Reduced 64.9%	81,432 $2.86 Million
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $196,566 - $347,853	-7,610 Reduced 3.18%	232,018 $7.57 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $332,082 - $397,849	8,769 Added 3.8%	239,628 $10.8 Million
Q3 2019 Nov 13, 2019	BUY	$40.31 - $43.45 $1.88 Million - $2.03 Million	46,625 Added 25.31%	230,859 $9.39 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $543,548 - $669,198	-15,570 Reduced 7.79%	184,234 $7.92 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $148,917 - $184,393	4,525 Added 2.32%	199,804 $7.67 Million
Q4 2018 Feb 15, 2019	SELL	$31.73 - $39.04 $159,506 - $196,254	-5,027 Reduced 2.51%	195,279 $6.9 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $197,242 - $232,089	-6,008 Reduced 2.91%	200,306 $7.71 Million
Q2 2018 Jul 18, 2018	BUY	$26.84 - $34.32 $154,410 - $197,442	5,753 Added 2.87%	206,314 $6.75 Million
Q1 2018 May 22, 2018	BUY	$25.2 - $28.54 $495,583 - $561,267	19,666 Added 10.87%	200,561 $5.48 Million
Q4 2017 Feb 13, 2018	BUY	$24.79 - $29.8 $393,045 - $472,479	15,855 Added 9.61%	180,895 $4.48 Million
Q3 2017 Nov 09, 2017	BUY	$26.26 - $29.17 $4.33 Million - $4.81 Million	165,040	165,040 $4.81 Million

Others Institutions Holding BSX

# of Institutions

1,543

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Boston Scientific Corp Transaction History